Controversias en la obtención del injerto hepático procedente de donante vivo

Adult liver transplants from a living donor are a valid and effective alternative as a treatment in terminal liver disease. However, in the context of a donation from a brain dead donor, as in western countries (Spain), it is very high, and there are still controversial aspects that should be continuously assessed in order to ensure good results. Live donations are currently stable and represent about 5% of the total liver transplants performed in Europe. Morbidity and mortality is around 35% and 0.1%, respectively, probably reasonable figures given the characteristics of the intervention. The 1 and 5 year survival rates of the recipients of a living donor are currently 95% and 75%, which are similar to those coming from brain dead donors. However the level of biliary complications in this patient group is higher, with an incidence of around 35-40%. However, this incidence has not had any effect on the long-term results up until now.